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Abstract
Purpose People with severe mental illnesses (SMI)
experience a 17- to 20-year reduction in life expectancy.
One-third of deaths are due to cardiovascular disease. This
study will establish the relationship of SMI with cardio-
vascular disease in ethnic minority groups (Indian, Pak-
istani, Bangladeshi, black Caribbean, black African and
Irish), in the UK.
Methods E-CHASM is a mixed methods study utilising
data from 1.25 million electronic patient records. Secondary
analysis of routine patient records will establish if differ-
ences in cause-specific mortality, cardiovascular disease
prevalence and disparities in accessing healthcare for ethnic
minority people living with SMI exist. A nested qualitative
study will be used to assess barriers to accessing healthcare,
both from the perspectives of service users and providers.
Results In primary care, 993,116 individuals, aged 18?,
provided data from 186/189 (98 %) practices in four inner-
city boroughs (local government areas) inLondon. Prevalence
of SMI according to primary care records, ranged from
1.3–1.7 %, across boroughs. The primary care sample inclu-
ded Bangladeshi [n = 94,643 (10 %)], Indian [n = 6086
(6 %)], Pakistani [n = 35,596 (4 %)], black Caribbean
[n = 45,013 (5 %)], black African [n = 75,454 (8 %)] and
Irish people [n = 13,745 (1 %)]. In the secondary care data-
base, 12,432 individuals with SMI over 2007–2013 con-
tributed information; prevalent diagnoses were schizophrenia
[n = 6805 (55 %)], schizoaffective disorders [n = 1438
(12 %)] and bipolar affective disorder [n = 4112 (33 %)].
Largest ethnic minority groups in this sample were black
Caribbean [1432 (12 %)] and black African (1393 (11 %)).
Conclusions There is a dearth of research examining
cardiovascular disease in minority ethnic groups with
severe mental illnesses. The E-CHASM study will address
this knowledge gap.
Keywords Severe mental illness  Ethnicity 
Cardiovascular disease  Schizophrenia  Bipolar affective
disorder
Background
People living with severe mental illnesses such as
schizophrenia have a reduced life expectancy relative to the
general population which is up to 20 years earlier in men
and 17 years in women, in high income countries [1, 2]. A
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large proportion of deaths are from chronic diseases,
including coronary heart disease and stroke [3]. Increased
mortality may be related to people with severe mental ill-
nesses receiving poorer quality physical healthcare [4–6].
There is also a higher prevalence of metabolic risk factors
such as obesity [7], hyperlipidaemia [8], diabetes [9]
together with higher smoking rates [10], in these popula-
tions. Anti-psychotic medications, especially at higher
doses, are associated with death from stroke and coronary
heart disease [11]. People with severe mental illnesses
experience barriers to seeking timely help for co-morbid
medical problems [12]. Finally, there may be shared factors
underlying premature mortality and severe mental illness,
such as social disadvantage [12].
Health inequalities may be even more pronounced
among ethnic minority populations with severe mental
illnesses [13, 14]. The reasons for this are unclear. There is
much evidence to suggest that those from ethnic minority
groups may experience disadvantage within the mental
healthcare system. Black people are more likely to be
compulsorily detained [15], be less satisfied with pre-
scribing [16] and more likely to be prescribed high-potency
antipsychotics at high doses [17–19]. In addition, physical
health monitoring may not be to the same standard as for
white patients [20]. The prevalence of cardiovascular dis-
ease is known to be elevated in people living with severe
mental illnesses and is also known to be of a greater con-
cern for some ethnic minority groups [21]. The exact nat-
ure of the interaction between being of an ethnic minority
background and living with severe mental illness, for the
risk of cardiovascular disease—is less clear. Previous
research examining cardiovascular disease health inequal-
ities by ethnicity in severe mental illness populations has
been limited by an over-reliance on small convenience
samples recruited from clinics, with limited representa-
tiveness and without the inclusion of adequate numbers of
people from ethnic minority groups to enable assessment of
prevalence of cardiovascular disease [14].
The E-CHASM study (ethnicity and cardiovascular
health inequalities in severe mental illness) described in
this protocol will draw upon electronic health records from
a large secondary care mental health Trust in England, as
well as data from primary care, to enable analyses exam-
ining the mechanisms for premature mortality due to car-
diovascular disease in ethnic minority people with severe
mental illnesses. The catchment areas for the study (south
east/east London) represent an ethnically and socioeco-
nomically diverse part of London, typical of many inner-
cities where ethnic minority communities reside and where
the burden of chronic health conditions is greatest.
E-CHASM will additionally utilise an embedded qual-
itative study, with integration of qualitative findings with
quantitative findings, adopting a mixed methods design
[22]. Using this approach, it may be possible to understand
trends revealed in quantitative data analysis, particularly
from the perspectives of service users, carers and clini-
cians/service providers, which will help to elucidate
mechanisms underlying quantitative findings.
Objectives
1. To understand the reasons for premature mortality in
ethnic minority people living with severe mental
illnesses; in particular to determine variations by
ethnicity in the following:
(a) The effect of severe mental illness on cardiovascular
risk factors;
(b) Cause-specific mortality patterns among people with
severe mental illnesses;
(c) Quality of care received, relevant to premature
mortality;
2. To develop and validate a measure for individual-
level socioeconomic position for application in a
large secondary care electronic mental health records
data resource, which will be used to improve the
assessment of the association of self-ascribed eth-
nicity with health-related outcomes.
3. To assess barriers to equitable physical healthcare
amongst ethnic minority people living with severe
mental illnesses, from the perspectives of service
users, their carers and clinicians.
Hypotheses (for quantitative data analyses)
Compared to white British people with severe mental ill-
nesses, ethnic minority service users with severe mental
illnesses will:
1. Have an elevated prevalence of cardiovascular disease
risk factors (hypertension, diabetes, obesity, raised
serum cholesterol, and smoking) and be less likely to
have had these adequately managed, as determined by
national standards for clinical management.
2. Be less likely to have cardiovascular disease risk
factors adequately screened or managed, when pre-
scribed neuroleptic medication;
3. Be more likely to be prescribed multiple antipsychotics
or antipsychotics at higher doses or outside recom-
mended dose ranges.
4. Experience differing causes of mortality (i.e., cause-
specific mortality fractions), in particular excess risk of
mortality due to coronary artery disease.
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Qualitative study aims
The aim of the qualitative phase of this study is to identify
barriers to delivering equitable physical healthcare (from
clinician perspectives) or in accessing healthcare (service
user and/or carer perspectives).
Qualitative study questions
1. What are the barriers to having physical health moni-
tored and treated in black and minority ethnic people
living with severe mental illness?
2. How are physical health problems related to cardio-
vascular disease managed by black and minority ethnic
participants living with severe mental illnesses?
Methods
Design
To address key objectives, this study will utilise anon-
ymised patient data from a variety of sources, some of
which will be linked together (e.g., secondary care patient
data linked to Office for National Statistics (ONS) mor-
tality data). This programme of research will follow a
quantitative study design leading on to a nested qualitative
study. In the final phase, results from the quantitative and
qualitative studies will be integrated.
Quantitative research methodology
Overview of data from primary care
Setting The London boroughs represented in the study
(Lambeth, Tower Hamlets, Newham, City and Hackney)
are notable for being home to the largest ethnic minority
communities in the UK, including Bangladeshi, black
Caribbean and black African communities; up to 51 % in
these areas comprise people of an ethnic minority back-
ground [23]. These areas are also characterised by high
population density and poverty [23, 24]. Tower Hamlets,
Newham and Hackney have the highest levels of depriva-
tion in England [25]. The location of the study is charac-
teristic of many other urban locations where ethnic
minority communities reside within the UK [24].
Measures from primary care The quality and outcomes
framework (QOF), a pay-for-performance scheme [26]
introduced into primary care in the UK in 2004 [27],
ensures that data quality is good for key indicators of health
[28–30]. Information from primary care records will be
extracted through data entered into structured fields in
primary care electronic patient records (Read Codes [31]).
Healthcare records contain information on consultation
rates, clinical measurement values, prescribing and health-
screening [28–30].
Demographic indicators
Information on patient age, gender and ethnicity will be
collected for analyses. Data will be linked to indices for
area-level deprivation, such as the index of multiple
deprivation [32], at small geographic level.
Severe mental illnesses
General practitioners are financially incentivised to main-
tain a register of people with severe mental illnesses.
Individuals with a diagnosis of schizophrenia, bipolar
affective disorder or non-organic psychosis, comprise
people on this register [31]. The use of computer-based
electronic records to identify patients with severe mental
illnesses in primary care has previously been validated,
with a sensitivity of 91 % and positive predictive value of
91 % for non-organic psychosis, assessed against a syn-
drome checklist derived from the Present State Examina-
tion and International Classification of Disease-9 (ICD-9)
[33], applied to clinical case notes [34]. Recent work has
shown that these diagnostic groupings remain stable over
time [35].
Cardiovascular disease indicators
Diagnostic read codes will be used to ascertain presence of
main cardiovascular health indicators. Diabetes mellitus,
hypertension, weight (body mass index), smoking status
and presence of hyperlipidaemia will be ascertained by
presence of diagnostic codes, blood test results and other
measurements (e.g., glycated haemoglobin (HbA1c), lipid
profile readings, etc.)
Psychotropic medications
Information on prescriptions of antipsychotic medications
according to formulation (oral/depot) and dose, will be
extracted and classified [36] prior to analyses.
Overview of data from secondary care
South London and Maudsley NHS Foundation Trust
Biomedical Research Centre (SLaM BRC) Case Register
This is an anonymised data resource drawn from the
electronic health records of over 250,000 service users who
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have received care from a large secondary mental health
service provider organisation (South London and Maudsley
NHS Foundation Trust)37. South London and Maudsley is
one of the largest mental health Trusts in Europe serving a
base population of approximately 1.2 million people [37]
living in south east London and using electronic health
records across all its services since 2006 (with some ser-
vices adopting these earlier). This data source contains all
patient contacts with Trust services including out-patient
appointments and in-patient admissions. The information
from the electronic health record is accessed via the
Clinical Record Interactive Search (CRIS) software sys-
tem, which permits free text and structured fields to be
searched for relevant information regarding patient char-
acteristics, interventions and outcomes. All data since 2007
will be used in the E-CHASM study.
Measures from secondary care
Demographic indicators
Information on age, gender and self-ascribed ethnicity will
be used. Area-level deprivation indicators matched to the
last census will be used in initial analyses; however, work
over the course of this study will lead to the derivation of a
variable for individual-level socioeconomic position, as
detailed below.
Psychotropic medications
Detail on antipsychotic medications will be derived from
the health records and classified into formulation (oral/
depot) and dose [36]. Information on medications pre-
scribed will be extracted from structured fields. In order to
minimise missing data on prescribed medications, natural
language processing with a bespoke algorithm will also be
used to extract relevant information on prescribing from
free text [38].
Mental disorder
Within South London and Maudsley Trust (SLaM), clinical
teams are required to assign mental disorder diagnoses for
all service users [37]. Diagnoses are entered into structured
fields on the electronic record. Due to auditing of diagno-
sis, completion rates for diagnostic fields are high [37].
Using information from these fields, supplemented by
natural language processing of free text and clinical note
fields [38], the following ICD-10 diagnostic groups will be
included in analyses: schizophreniform disorders (F20–
F29), mania and bipolar affective disorder (F30, F31).
Cause-specific mortality
All electronic patient records contained within this
dataset have a unique NHS patient identifier which can
be linked to death certificate information nationally.
Lists of deceased patients are downloaded on a monthly
basis from the NHS care records service. To ascertain
cause of death, information from linked death certificates
will be extracted and categorised according to ICD-10
[39].
Development of a measure for individual-level
socioeconomic position
Much important information is captured within the free-
text information fields of electronic patient records [40,
41], particularly in mental healthcare. Using computa-
tional techniques such as natural language processing
may help to unlock this information from within these
text fields [41]. Within the SLaM-BRC Case Register,
this has already been applied to derive information on
cognition [42], smoking [43], pharmacotherapy [38] and
symptoms [44]. The software [General Architecture for
Text Engineering (GATE)] is an open source package
used for natural language processing [45]. For example,
in a study designed to assess smoking use, natural lan-
guage processing supplemented information within
structured fields, leading to an increase in proportions
identified as smokers, from 11.6 % (when reliant on
structured fields alone) to 64 % (when supplemented by
natural language processing of free text) [43]. This
approach is robust and repeatable [43]. Algorithms using
GATE will be developed to derive indicators for
socioeconomic position, through first ascertaining a pri-
ori keywords indicative of socioeconomic position, fol-
lowed by an iterative process of: (1) developing a
bespoke gazetteer of terms related to socioeconomic
position (together with synonyms), and rules and models
for extracting socioeconomic position; (2) evaluating the
real world use and applicability of these terms and rules
in routine clinical records. At least two indicators of
socioeconomic position will be derived: education and
occupational social class. Education is a valuable mea-
sure of socioeconomic position as it reflects early life
socioeconomic position and is strongly related to parental
characteristics [46]. Occupational social class is an
important measure of socioeconomic position as it taps
into individual social standing, conditions relating to
work-based stress, and is also predictive of income and
material resources [46]. Both have clear associations with
mental and physical health [46, 47].
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Analyses
1. To determine ethnic variations in cause-specific mor-
tality patterns among people with severe mental
illnesses.
Data from secondary care will be used. ‘Cohorts’ of indi-
viduals by severe mental illness diagnoses (e.g., F20
Schizophreniform disorders F30/F31 Bipolar Affective
Disorder and Manic episodes) will be followed from 2007
until the latest date at which linked census information on
mortality and cause of death are available. Mortality rates
by severe mental illness diagnosis will be obtained, indi-
rectly age- and gender-standardised to the population of
England and Wales. Indirectly standardised SMRs by eth-
nic group will also be obtained.
2. To determine ethnic variations in the effect of SMI on
cardiovascular risk factors.
Data from primary care will be used. The association of
severe mental illness with cardiovascular risk factors (such
as type 2 diabetes mellitus, hypertension, obesity, tobacco
use and 10-year cardiovascular mortality risk, such as
QRISK [48]) will be assessed using multivariable logistic
regression, adjusting or stratifying for age and gender as
appropriate. Odds ratios stratified by ethnicity for the
association of severe mental illness with cardiovascular
disease risk will be obtained, in order to assess for ethnic
variations in the effect of severe mental illness on cardio-
vascular risk factors. Formal tests of statistical interaction
will be used to assess for heterogeneity in the association of
severe mental illness with cardiovascular disease risk fac-
tors across strata. The role of putative mediators, such as
health-related behaviours, e.g., smoking, antipsychotic
medication prescriptions and weight or body mass index,
will be assessed using formal procedures to test for medi-
ation [49].
3. To determine ethnic variations in quality of care
received, relevant to premature mortality.
‘Poor quality’ of care will be deemed present when
therapeutic interventions fall outside of nationally recog-
nised guidelines, in the UK. This might include a failure to
adequately screen and manage physical health comorbidi-
ties (as detected in primary care data sources), or in the
prescribing of antipsychotic medications in excess of rec-
ommended dose. Multivariable logistic regression will
assess the association of ethnicity (with ‘white British’ as
the reference) with each of the care indicators, adjusting or
stratifying by age and gender, as appropriate.
4. Validation of the measure for individual-level socioe-
conomic position, derived using structured field infor-
mation and natural language processing.
The construct and concurrent validity of the GATE-
derived socioeconomic position indicators of education and
occupational social class will be assessed using structural
equation modelling against a nested cohort of 558 individ-
uals with psychosis [50]. These individuals presented to
South London and Maudsley Trust services with a first epi-
sode of psychosis between 1st May 2010 and 30th April
2012. Individuals within this cohort were aged 18–64.
Information on education and occupation were extracted
from patient records by research workers, using the Medical
Research Council (MRC) socio-demographic schedule [51].
Sample size calculation
The following table details detectable effect sizes at 80 %
power. There is greater power to detect associations in the
primary care sample for each of the ethnic groups, as it is a
larger sample (Table 1).
Qualitative study
Methodology
To address the objectives for the qualitative work, focus
groups and interviews will be conducted with patients and
Table 1 Smallest effect sizes
(odds ratios) detectable for the
largest and smallest ethnic
minority groups at 80 % power
(with two sided 5 %
significance levels), for
exposures with a prevalence of
10, 20 and 50 % in the reference
(white British) group
Primary care data source N Prevalence of outcome in white British group
White British 238,211 10 % 20 % 50 %
Smallest detectable odds ratio
Bangladeshi 93,143 1.03 1.02 1.01
Irish 13,459 1.08 1.05 1.03
Secondary care data source N Prevalence of outcome in white British group
white British 28,618 10 % 20 % 50 %
Smallest detectable odds ratio
‘Other’ white 4477 1.14 1.09 1.05
Indian 711 1.35 1.23 1.11
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clinicians. Focus groups stimulate discussion and involve
group processes that can help people to explore and clarify
views and provide insight into cultural values and norms.
Up to eight focus groups, each comprising 6–8 participants
will be facilitated by two interviewers, with one group
comprising clinicians and at least one group containing
individuals who identify their ethnicity as ‘white Bri-
tish’. In practice, the actual number of focus groups to be
conducted will be determined by the range of relevant
characteristics that emerge from the quantitative work
and how these might best be reflected and balanced
within the focus groups [52]. The purpose of the groups
will be to understand the perspectives of service users
and their carers, in particular experiences of living with
cardiovascular disease co-morbid with severe mental
illnesses and to identify barriers as well as facilitators to
accessing healthcare.
Individual qualitative interviews will then be conducted
to further explore the personal experience and relevance of
themes identified from the focus groups. It is envisaged that
up to twenty individual interviews will be conducted for
this purpose.
Purposive sampling will be used to identify participants
for both the focus groups and the individual interviews.
The criteria for this will be determined after examination of
the quantitative data (which may for example give an
indication of which ethnic minority groups with severe
mental illnesses experience physical health inequalities).
This process is described in more detail next.
Sampling frame for qualitative research
For people living with severe mental illness, the ‘Consent
for Contact’ programme [47], a register of South London
and Maudsley Trust service users who are willing to be
contacted about research projects on the basis of informa-
tion in their record, will be used to purposively sample
participants who have a severe mental illness co-morbid
with a known physical health condition. To date, of a total
of 9564 service users approached to take part in the
‘Consent for Contact’ programme, 72 % have consented to
being contacted for mental health research. There are
approximately 1340 individuals with severe mental ill-
nesses, who will form the main pool of participants to be
approached to take part in focus groups and interviews for
the qualitative part of the study. As this register is linked to
the electronic patient record data source detailed above,
purposive sampling will be based on characteristics con-
sidered important for the composition of the groups (e.g.,
ethnicity and/or presence of a physical health problem).
The composition of focus groups will be informed by
findings from the quantitative analyses, which will high-
light where inequalities with cardiovascular health in
people living with severe mental illness are most pro-
nounced. Stratification [52] will be used to ensure a
diversity of people representative of the population are
included in the study, dependent on the types of question
generated by quantitative findings and may for example
include people living with severe mental illnesses who
have also been diagnosed with type 2 diabetes mellitus.
Topic guide for qualitative study
Topic guides will be semi-structured. Domains to be cov-
ered in the topic guide will include: experiences of
accessing/using mental and physical healthcare, the use of
alternative therapies and medical models, experiences of
physical symptoms, use of biomedical treatments and dis-
ease monitoring, perceptions of stigma/discrimination from
health service providers and individuals. Other domains
will include perceived barriers to care, including language,
recent migration and knowledge of local services. The
topic guide will be further developed following feedback
from service user representatives.
Analysis of qualitative data and integration
with quantitative findings
Thematic content analysis will be used to identify salient
themes, until no further themes emerge. Analyses will be
iterative as emergent themes will be used to generate
hypotheses which may be tested in the quantitative
dataset. Coding of qualitative data will be through
appropriate software (N-Vivo) [53]. Emergent themes
and coding frameworks will be cross-checked with
researchers with expertise in qualitative research. Find-
ings from the qualitative phase will be triangulated with
those from the quantitative phase. A triangulation pro-
tocol will be used to identify ‘meta-themes’ relevant to
findings from both quantitative and qualitative phases of
the study [54] and in particular, areas of convergence or
divergence.
Ethical standards
All data will be anonymised and managed according to UK
National Health Service (NHS) information governance
(IG) requirements.
Ethical approval to examine data from the South London
and Maudsley Trust Biomedical Research Centre Case
Registry (SLaM BRC case registry) as an anonymised
dataset for secondary analysis has been obtained from
632 Soc Psychiatry Psychiatr Epidemiol (2016) 51:627–638
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Oxfordshire REC C in 2008 and renewed in 2013 (refer-
ence number 08/H0606/71?5). Methods to de-identify data
have been published and are robust [55]. Separate
approvals to conduct the analyses proposed within this
protocol have been granted by the CRIS Oversight
Committee.
The South London Primary Care Research Governance
Team reviewed the process of anonymised data analysis for
patient data from Lambeth and approved the usage of
aggregated anonymised patient data for research purposes.
Lambeth Clinical Commissioning Group, Information
Governance Steering Group (Lambeth CCG IGCG) has to
approve each research project based on individual appli-
cations using a standardised proforma, the ‘Privacy Impact
Statement’.
For data from east London (Newham, Tower Hamlet,
City and Hackney), each of the practices opted into the
study by signing forms permitting the Clinical Effective-
ness Group (CEG) to use anonymised aggregated data for
audits and research projects supported by the CEG. Infor-
mation Technology (IT) information governance commit-
tees provided approval for each of the three localities
covered by the CEG.
Qualitative study Separate ethical approval will be
sought for the qualitative part of the study once the topic
guide and likely composition of focus groups have been
finalised, following completion of initial analyses of
quantitative data.
Results
Primary care
The primary care database comprises approximately 1.06
million patient records, including 358,614 anonymised
electronic patient records registered to 47 (of 48) general
practices in Lambeth and 697,600 anonymised records of
patients registered to 142 (of 144) general practices in East
London (Tower Hamlets, Newham, City and Hackney) (in
total 98.3 % of practices). Data on age and gender are near
complete, since these are recorded routinely at patient
registration. Self-ascribed ethnicity according to Office for
National Statistics (ONS) census categories is available for
80–90 % of patients, following local schemes to improve
the recording of ethnicity [28–30, 56].
People registered to general practitioners/family doctors
within the primary care database are more likely to reside
in areas which are deprived and a high proportion of res-
idents in each of the boroughs report their ethnicity as
being of minority status (Table 2). Prevalence of severe
mental illnesses ranges from 1.3–1.7 %, by borough
Table 2 Characteristics of primary care database, sample restricted to 18?
Lambeth Tower Hamlets Newham City and Hackney
Participants N (%) 295,516 (30) 214,600 (21.6) 282,512 (28.4) 200,488 (20.2)
Practices N (%) 47 (25) 37 (20) 64 (34) 41 (22)
Proportion resident in most deprived areasa N (%) 254,593 (86.2) 169,036 (90.0) 263,681 (98.8) 176,463 (97.7)
Proportion ethnic minorities N (%) 152,307 (62.1) 133,727 (68.2) 220,549 (84.0) 118,637 (66.9)
Prevalence severe mental illness
N 4718 3477 3706 3484
% (95 % CI) 1.60 (1.55, 1.64) 1.62 (1.57, 1.67) 1.31 (1.27, 1.35) 1.74 (1.68, 1.80)
Prevalence type 2 diabetes
N 13,372 13,479 20,309 10,754
% (95 % CI) 4.54 (4.47, 4.62) 6.30 (6.20, 6.40) 7.20 (7.11, 7.30) 5.38 (5.28, 5.48)
Prevalence hypertension
N 32,454 22,238 38,632 24,993
% (95 % CI) 10.98 (10.87, 11.10) 10.36 (10.23, 10.49) 13.67 (13.55, 13.80) 12.47 (12.32, 12.61)
Prevalence ischaemic heart disease
N 5103 4792 6759 4226
% (95 % CI) 1.73 (1.68, 1.77) 2.23 (2.17, 2.30) 2.39 (2.34, 2.45) 2.11 (2.05, 2.17)
Current or ex-smoker
N 132,741 48,266 47,749 46,412
% (95 % CI) 46.62 (46.44, 46.80) 50.40 (50.08, 50.72) 40.31 (40.02, 40.59) 50.33 (50.00, 50.65)
a Bottom two quintiles for index of multiple deprivation 2000 at lower super output level; prevalence estimates based on number of patients on
quality and outcomes framework (QoF) registers for each disease, crude estimates
Soc Psychiatry Psychiatr Epidemiol (2016) 51:627–638 633
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(Table 2). Figure 1 highlights the geographical distribution
of severe mental illness across the study sites.
Compared to people registered to general practitioners
and not known to have a severe mental illness, the severe
mental illness sample in primary care were older, with a
higher proportion of men, a larger proportion of people
reporting their ethnicity as white British or black Caribbean
and were more likely to reside in deprived areas (Table 3).
Secondary care
The secondary care database currently comprises approxi-
mately 260,000 anonymised patient records [37], and has
increased consistently by around 20,000 per year. Age and
gender are complete in this database. Ethnicity is self-
ascribed according to standardised criteria, consistent with
the last census. Information on self-ascribed ethnicity was
93–97 % complete in 2007–2013. Table 4 displays ICD-10
diagnoses for severe mental illnesses by ethnicity, for this
database.
Discussion
People living with severe mental illnesses experience a
dramatic reduction in life expectancy [1], a large pro-
portion is accounted for through cardiovascular disease
[3]. Although complex [57], a parallel body of work has
highlighted the particular problem of cardiovascular
disease for many ethnic minority groups [21, 58, 59]. It
is, therefore, surprising that there is a dearth of evidence,
relating to cardiovascular disease in ethnic minority
groups living with severe mental illnesses [14]. This is a
concern, as this represents preventable causes of death.
The present study, E-CHASM, will address this gap in
knowledge.
Fig. 1 Prevalence of severe mental illnesses across the study sites, by borough
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The results presented suggest that the prevalence of severe
mental illness in the study catchment area is greater than
previously published estimates for prevalence of psychotic
disorders in Britain, which have been noted to range from 0.4
to 0.8 %, with considerable variability between geographi-
cal regions [60]. Local areal estimates for severe mental
illness are, however, broadly consistent with those published
by Public Health England [59]. Cardiovascular disease
indicators presented here are broadly consistent with
prevalence estimates published for London [60].
The feasibility of E-CHASM rests on its usage of rou-
tine electronic patient records to establish differences in
Table 3 Characteristics of
people living with severe mental
illnesses in primary care
database, sample restricted to
adults aged 18?
Not on SMI registera
N = 997,731
Severe mental illness (SMI register)a
N = 15,385
Total
N % N % N
Age (mean, SD) 40 (15.5) 47 (15.3) 993,116
Sex
Men 494,304 51 8488 55 502,792
Women 483,426 49 6897 45 490,323
Ethnicity
White British 238,211 27 4403 31 242,614
Irish 13,459 2 286 2 13,745
‘Other’ white 171,493 20 1442 10 172,935
Indian 60,298 7 566 4 60,864
Pakistani 35,215 4 381 3 35,596
Bangladeshi 93,143 11 1500 10 94,643
Black Caribbean 43,367 5 1646 11 45,013
Black African 74,037 9 1417 10 75,454
‘Other’/Chinese 110,094 13 2027 14 112,121
Mixed ethnicity 27,877 3 717 5 28,594
Area-level deprivation (quintiles)
1 Most deprived 587,820 64 10,437 71 589,257
2 261,966 29 3550 24 265,516
3 51,207 6 521 4 51,728
4 10,396 1.1 96 0.7 10,492
5 Least deprived 4626 0.5 21 0.1 4647
a Severe mental illness refers to patients with any of schizophrenia, schizoaffective disorder, bipolar
affective disorder and any non-organic psychosis
p\ 0.001 for all sociodemographic variables; comparing SMI to non-SMI group
Table 4 Breakdown of severe
mental illness diagnosis by
ethnicity in secondary care
database, 2007–2013
Schizophrenia Schizoaffective disorder Bipolar affective disorder
N = 6885 N = 1438 N = 4112
Ethnicity, n (%)
White British 2271 (33) 519 (36) 2033 (49)
‘Other’ white 473 (7) 93 (6) 376 (9)
Irish 141 (2) 37(3) 132 (3)
Indian 131 (2) 21 (1) 64 (2)
Pakistani 55 (0.1) 10 (0.7) 24 (0.6)
Bangladeshi 29 (0.4) 8 (0.6) 18 (0.4)
Black Caribbean 1004 (15) 173 (12) 255 (6)
Black African 926 (13) 194 (13) 273 (7)
‘Other’/Chinese 1472 (21) 284 (20) 606 (15)
Mixed ethnicity 97 (1) 22 (1.5) 48 (1)
Not stated/missing 286 (4) 71 (4.9) 257 (6)
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prevalence and treatment access. In particular, analyses of
records from patients registered to general practices in an
ethnically and socioeconomically diverse region in a major
inner-city conurbation, alongside analysis of records from a
large mental health Trust serving these populations, will
enhance the study. The enriched representation of popu-
lations normally under-represented or absent in similar
work [14] will allow the assessment of ethnic minority
physical health inequalities in severe mental illness popu-
lations. Methodological techniques such as natural lan-
guage processing to data-mine free text within secondary
care records [41, 45] will enable development of measures
for socioeconomic position through robust and repeat-
able methods which will also enable the automation of
checking of a large volume of records which would
otherwise be impossible [41]. As far as we are aware, the
derivation of an individual-level measure for socioeco-
nomic position from routine electronic health records has
not been previously attempted. Finally a novel application
of using electronic patient records in research is in the
application of the ‘consent for contact’ programme at
South London and Maudsley Trust. Thus, following anal-
ysis of quantitative data, it will be possible to purposively
sample potential participants who will be invited to take
part in focus groups and individual interviews for the
qualitative phase of this study, based on important attri-
butes (e.g., type of diagnosis, ethnicity, presence of phys-
ical comorbidity). Thus, the findings from the quantitative
phase will directly inform qualitative data collection. This
form of integration, known as ‘connecting’, will draw from
the strengths of deductive methods in the quantitative
phase to inform study design for the qualitative phase [22].
Integration of findings across qualitative and quantitative
data sources [54] will help to understand mechanisms
underlying quantitative findings as well as identify barriers
to care from the perspectives of service users, carer and
service providers. A future application of this data source
could be to assess discrepancies in care provided across
primary and secondary care. This would be based on data
linkages between primary and secondary care, which could
be explored in future work.
Strength and limitations
Strengths of this study include the power to conduct sta-
tistical analyses in groups of individuals who form a
minority in the population and thus address the current
scarcity of research in this field. Other strengths include the
usage of natural language processing to derive a measure
for individual-level socioeconomic position. If successful,
this will provide a methodological advantage, as almost all
previous work using electronic health records has tended to
rely on area-level measures for deprivation. The mixed
methods design of the study will enhance possibilities of
understanding trends in quantitative analyses as well as
highlighting barriers to equitable care from the perspec-
tives’ of service users and service providers. In all of the
quantitative data sources, ethnicity is self-ascribed. This is
an addition over previous work which has tended to rely on
country of birth [61].
Limitations relate to analysing routine electronic patient
records, where missing data may be associated with bias
and loss of precision [62]. There may also be concerns
around the quality of the data entered on databases and
variables to adjust for known confounders may not be
available [63]. It may be possible to apply specialist
techniques to address this [62–64]. For the cross-sectional
phases of the study, it will not be possible to conclude
temporality of associations.
Dissemination
Analyses will be disseminated in peer-reviewed manu-
scripts and through conference proceedings. If requested,
analyses will also be prepared as reports or presentations
for interested stakeholders. Findings relating directly to
clinical care will be fed back to clinical care networks, with
a view to informing guideline development.
Conclusions
There is currently an absence of evidence relating to life
expectancy differences in ethnic minority people living
with severe mental illnesses such as schizophrenia. In
particular, little is known about the experience of cardio-
vascular disease in these populations and whether there are
additional barriers or inequities in service provision.
E-CHASM will seek to address these gaps in knowledge
through a combination of quantitative analysis of electronic
health records and qualitative interviews.
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